Severity of depression and response to antidepressants: GENPOD randomised controlled trial.
BACKGROUND: Antidepressant prescribing is widespread. Nonetheless, response to antidepressants is variable. If it was possible to predict response to medication and thus tailor treatment accordingly, this would not only improve patient outcomes but may also have economic benefits. AIMS: To test the...
Κύριοι συγγραφείς: | Wiles, N, Mulligan, J, Peters, T, Cowen, P, Mason, V, Nutt, D, Sharp, D, Tallon, D, Thomas, L, O'Donovan, M, Lewis, G |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2012
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol.
ανά: Thomas, L, κ.ά.
Έκδοση: (2008) -
GENetic and clinical Predictors Of treatment response in Depression: the GenPod randomised trial protocol
ανά: O'Donovan Michael, κ.ά.
Έκδοση: (2008-05-01) -
Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.
ανά: Wiles, N, κ.ά.
Έκδοση: (2014) -
Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.
ανά: Lewis, G, κ.ά.
Έκδοση: (2011) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
ανά: Crawford, A, κ.ά.
Έκδοση: (2014)